台股 » 個股 » 台新藥 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

台新藥

(6838)
  • 股價
    34.75
  • 漲跌
    ▲0.70
  • 漲幅
    +2.06%
  • 成交量
    137
  • 產業
    上市 生技醫療類股
  • 20人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
台新藥 (6838)籌碼相關-犇亞-鑫豐 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

犇亞-鑫豐 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/0900.00134.9034.30-1309-0.32%
2025/01/08135.1000.0035.0513160.32%
2024/12/180.138.4500.0038.100.15270.01%
2024/12/13039.751239.4039.00-12587-2.04%
2024/12/1200.00339.6539.65-3629-0.48%
2024/12/11039.7000.0039.6006430.00%
2024/12/10139.8500.0039.8016730.15%
2024/12/09039.6000.0039.6007300.00%
2024/12/06140.6500.0040.3017760.13%
2024/12/05540.50140.5540.4547830.51%
2024/12/04541.4800.0041.6057820.64%
2024/12/03042.51141.6541.75-1786-0.13%
2024/12/0200.009.243.5243.00-9.2782-1.18%
2024/11/291142.3100.0042.50117671.43%
2024/11/27238.7800.0038.7027660.26%
2024/11/26039.2000.0039.3507700.00%
2024/11/25039.2000.0039.1007760.00%
2024/11/22239.0000.0038.9527800.26%
2024/11/21138.7700.0038.9017840.13%
2024/11/2000.00239.7039.25-2790-0.25%
2024/11/1900.00439.6039.65-4796-0.50%
2024/11/18239.4500.0039.9028130.25%
2024/11/15042.00042.0041.7008150.00%
2024/11/14042.6000.0041.2508240.00%
2024/11/13042.9000.0042.6008340.00%
2024/11/12043.5000.0042.7008760.00%
2024/11/07044.1000.0044.3509770.00%
2024/11/06045.00146.1544.35-1980-0.10%
2024/11/05146.5500.0046.5519780.10%
2024/11/0400.002.245.7145.80-2.2972-0.22%
2024/11/01245.0000.0045.3029660.21%
2024/10/23043.85143.8044.00-1977-0.10%
2024/10/2200.00243.8043.75-2981-0.20%
2024/10/21044.7000.0044.3009830.00%
2024/10/17045.0500.0044.5009930.00%
2024/10/16144.7000.0044.5019970.10%
2024/10/15044.751444.5343.55-141,008-1.39%
2024/10/14045.756444.9944.75-641,001-6.39%
2024/10/11445.86245.4045.7529990.20%
2024/10/0900.00145.9546.00-1991-0.10%
2024/10/08246.84148.0546.3519850.10%
2024/10/0700.00248.5348.25-2970-0.21%
2024/10/041848.89348.3848.65159561.57%
2024/10/01149.4000.0049.2519350.11%
2024/09/3000.001348.2548.25-13880-1.48%
2024/09/27143.85144.3043.9008380.00%
2024/09/26043.3000.0042.7508350.00%
2024/09/2500.00143.4043.15-1835-0.12%
2024/09/241344.0000.0043.50138411.54%
2024/09/236844.88245.1044.45668307.95%
2024/09/20144.60145.1044.6008220.00%
2024/09/19244.9000.0044.9028170.24%
2024/09/1800.00245.4343.95-2802-0.25%
2024/09/16345.3010344.6144.65-100798-12.52% 大賣/
2024/09/1310445.9924.144.7146.058077810.27% 大買/
2024/09/12542.4818142.1041.90-176736-23.89% 大賣/鉅額交易
2024/09/112443.602343.3042.5017230.14%
2024/09/106545.716945.8145.50-4694-0.58%
2024/09/0911141.880.142.1543.75110.963517.44% 大買/鉅額交易
2024/09/05037.6000.0037.2505810.00%
2024/09/04037.6500.0037.2505790.01%
2024/09/03038.8500.0038.5505730.00%
2024/09/02039.90239.1538.90-2574-0.34%
2024/08/2600.00139.0538.90-1552-0.18%
2024/08/16139.750.239.9039.650.84980.16%
2024/08/150.240.1000.0039.900.24890.04%
2024/08/14640.138640.7939.55-80477-16.76%
2024/08/138640.00441.5841.958243818.69%
〈焦點股〉台新藥眼科新藥出貨至美國展望正向 觸及漲停Anue鉅亨-2024/09/13
〈焦點股〉台新藥眼科新藥9月正式外銷至美國 漲逾半根停板Anue鉅亨-2024/09/06
台新藥 相關文章
台新藥 相關影音